Cargando…

EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway

BACKGROUND: As a member of the ERM (ezrin-radixin-moesin) protein family, EZR has been recognized as a regulator of adhesion signal pathways by researchers. Moreover, EZR was thought to play irreplaceable roles in invasion and metastasis of versatile cancers. In this study, we managed to undermine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jian, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502343/
https://www.ncbi.nlm.nih.gov/pubmed/34627255
http://dx.doi.org/10.1186/s12935-021-02222-1
_version_ 1784580877167099904
author Xu, Jian
Zhang, Wei
author_facet Xu, Jian
Zhang, Wei
author_sort Xu, Jian
collection PubMed
description BACKGROUND: As a member of the ERM (ezrin-radixin-moesin) protein family, EZR has been recognized as a regulator of adhesion signal pathways by researchers. Moreover, EZR was thought to play irreplaceable roles in invasion and metastasis of versatile cancers. In this study, we managed to undermine the effect of EZR on proliferation and metastasis in pancreatic cancer (PC). METHODS: To analyze the impact of EZR expression on overall survival and free diseases survival of PC patients, we screened abnormally expressed EZR in PC using the Gene Expression Omnibus database (GEO database) and The Cancer Genome Atlas (TCGA) database. Following, Gene Ontology (GO)-based functional analysis and Gene set enrichment analysis (GSEA) was performed to predicate the possible biological processes in which EZR were involved. The clinicopathological characteristics and prognosis of PC patients were analyzed according to clinical data. Further, immunohistochemistry, western blotting and real time PCR analysis were conducted to analyze the expression level of EZR in PC and paired paracancerous tissues. The effect of EZR on proliferation of PC cell lines were detected by Cell Counting Kit-8 assay, and meanwhile, Transwell assay was performed to detect the effect of EZR on invasion and migration of PC cell. RESULT: EZR exhibited higher expression level in pancreatic cancer tissues and cell than paracancerous tissues and cell, and its expression level was positively correlated with poor overall survival and diseases-free survival in PC patients. CCK8 assay indicated that EZR facilitated the proliferation of PC cells, meanwhile, Transwell assay showed that EZR promoted the migration and invasion of PC cells. The GO analysis predicated that EZR was involved in biological processes including cell adhesion, ameboidal-type cell migration, cell junction assembly. Through GSEA analysis, pancreatic cancer pathway, and the adhesion junction pathway were screened as the mostly enriched pathways in EZR-regulated pathological process. The inhibition of EZR suppressed proliferation and migration of PC cells. Western blot experiment revealed a positive correlation between EZR and FAK, the proliferation invasion and migration ability of PC cells were significantly decreased after knockdown of EZR. CONCLUSION: Our finding revealed EZR accelerated the progression of PC via FAK/AKT signaling pathway. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02222-1.
format Online
Article
Text
id pubmed-8502343
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85023432021-10-20 EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway Xu, Jian Zhang, Wei Cancer Cell Int Primary Research BACKGROUND: As a member of the ERM (ezrin-radixin-moesin) protein family, EZR has been recognized as a regulator of adhesion signal pathways by researchers. Moreover, EZR was thought to play irreplaceable roles in invasion and metastasis of versatile cancers. In this study, we managed to undermine the effect of EZR on proliferation and metastasis in pancreatic cancer (PC). METHODS: To analyze the impact of EZR expression on overall survival and free diseases survival of PC patients, we screened abnormally expressed EZR in PC using the Gene Expression Omnibus database (GEO database) and The Cancer Genome Atlas (TCGA) database. Following, Gene Ontology (GO)-based functional analysis and Gene set enrichment analysis (GSEA) was performed to predicate the possible biological processes in which EZR were involved. The clinicopathological characteristics and prognosis of PC patients were analyzed according to clinical data. Further, immunohistochemistry, western blotting and real time PCR analysis were conducted to analyze the expression level of EZR in PC and paired paracancerous tissues. The effect of EZR on proliferation of PC cell lines were detected by Cell Counting Kit-8 assay, and meanwhile, Transwell assay was performed to detect the effect of EZR on invasion and migration of PC cell. RESULT: EZR exhibited higher expression level in pancreatic cancer tissues and cell than paracancerous tissues and cell, and its expression level was positively correlated with poor overall survival and diseases-free survival in PC patients. CCK8 assay indicated that EZR facilitated the proliferation of PC cells, meanwhile, Transwell assay showed that EZR promoted the migration and invasion of PC cells. The GO analysis predicated that EZR was involved in biological processes including cell adhesion, ameboidal-type cell migration, cell junction assembly. Through GSEA analysis, pancreatic cancer pathway, and the adhesion junction pathway were screened as the mostly enriched pathways in EZR-regulated pathological process. The inhibition of EZR suppressed proliferation and migration of PC cells. Western blot experiment revealed a positive correlation between EZR and FAK, the proliferation invasion and migration ability of PC cells were significantly decreased after knockdown of EZR. CONCLUSION: Our finding revealed EZR accelerated the progression of PC via FAK/AKT signaling pathway. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02222-1. BioMed Central 2021-10-09 /pmc/articles/PMC8502343/ /pubmed/34627255 http://dx.doi.org/10.1186/s12935-021-02222-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Xu, Jian
Zhang, Wei
EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway
title EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway
title_full EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway
title_fullStr EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway
title_full_unstemmed EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway
title_short EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway
title_sort ezr promotes pancreatic cancer proliferation and metastasis by activating fak/akt signaling pathway
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502343/
https://www.ncbi.nlm.nih.gov/pubmed/34627255
http://dx.doi.org/10.1186/s12935-021-02222-1
work_keys_str_mv AT xujian ezrpromotespancreaticcancerproliferationandmetastasisbyactivatingfakaktsignalingpathway
AT zhangwei ezrpromotespancreaticcancerproliferationandmetastasisbyactivatingfakaktsignalingpathway